MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Companies

Companies

Displaying 1..10 of 39 - per page Next page
Order by
PALAU PHARMA is a product-driven specialty pharmaceutical company devoted to the discovery and development of safer medicines for the treatment of inflammatory and autoimmune conditions. More
The worldwide leader in market research publications, advisory services and consulting More
NEURON BPh, one of the fastest growing Spanish Biotech Companies More
Medinnova identifies, protects and commercialises inventions and discoveries of the Oslo University Hospital and other health enterprises in the south-east of Norway. More
Supernus Pharmaceuticals is a specialty pharmaceutical company specific expertise in developing differentiated products in collaboration with partners and for its own CNS product portfolio. More
Valeant Pharmaceuticals is a US based specialty company with capabilities from R&D through Manufacturing and Sales and Marketing in all major world markets. More
Elan Corporation, plc, headquartered in Dublin, Ireland, is a leading world-wide drug delivery and speciality biopharmaceutical company. More
ReGen is an early-stage biopharmaceutical company developing Colostrinin (a natural sourced material) for Alzheimers. Colostrinin may also have utility as a neutraceutical More
Zapaloid uses proprietary technology to develop innovative disease-modifying therapeutic strategies against protein misfolding diseases, such as Type 2 diabetes, Parkinson's and Alzheimer's disease More
Is committed to building on success, and the continued in-licensing of products and technologies is an acknowledged strategic priority More
Displaying 1..10 of 39 - per page Next page
Order by

Your selection

Therapeutic target
Central Nervous System del
Neurodegenerative disorders del
Alzheimer's disease del

Browse By

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
BioTrinity
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us